4/A

OWNERSHIP DOCUMENT

Company: BioXcel Therapeutics, Inc.
Filed: June 18, 2024
Period of Report: March 14, 2023
Accession Number: 0001104659-24-072998

View Document ↗ View on SEC.gov ↗